Citations 1
Metabolic inflammation and cancer risk: A potential target with GLP‐1 agonist or bariatric surgery?
Cheung, Dillon, Yu, Stephanie, Lim, Pei‐Wen , Fong, Zhi Ven , Fong, Zhi Ven
Cancer | October 15, 2025 | Volume: 131 | Issue: 20 | Pages: No page available
The authors explore the association of remnant cholesterol and CRP with the longitudinal development of cancer in a prospective cohort study and if there is an opportunity to modulate risk with bariatric surgery or GLP‐1 agonist.